With 14 acquisitions under our belt in last 5 years, we are ready for more: Pradeep Nair, Managing Director - India, Cole-Parmer

We are also acquiring company into lab equipment. We have product that meets the requirement of laboratory equipment from end to end.

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance

PI Industries announces twin acquisitions into Pharma API & CDMO space

CliniSys creates world’s largest diagnostics and lab informatics with recent acquisitions

CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe

Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1

The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio

Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit

As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%

Pfizer CFO Dave Denton to exit

Pharma powerhouse names Cecile Guegan interim finance chief

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges

Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla

Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.

Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market

Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq